UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT
TO SECTION 12(b) OR 12(g) OF THE
SECURITIES
EXCHANGE ACT OF 1934
CHINA CORD BLOOD
CORPORATION
(Exact
Name of Registrant as Specified in its Charter)
|
Cayman
Islands
|
Not
Applicable
|
|
|
(State
of Incorporation or Organization)
|
(I.R.S.
Employer Identification No.)
|
48th
Floor, Bank of China Tower
1 Garden
Road
Central
Hong Kong
S.A.R.
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Securities
to be registered pursuant to Section 12(b) of the Act:
|
Title
of Each Class to be so Registered
|
Name
of Each Exchange on Which Each Class is to be
Registered
|
|
|
Ordinary
Shares, $0.0001 par value
|
New
York Stock Exchange
|
|
|
If
this Form relates to the registration of a class of securities pursuant to
Section 12(b) of the Exchange Act and is effective pursuant to General
Instruction A.(c), please check the following box. x
|
If
this Form relates to the registration of a class of securities pursuant to
Section 12(g) of the Exchange Act and is effective pursuant to General
Instruction A.(d), please check the following box. ¨
|
Securities
Act registration statement file number to which this form relates:
333-161602
Securities
to be registered pursuant to Section 12(g) of the Act:
______________.
Item
1. Description
of Registrant's Securities to be Registered.
A
description of the ordinary shares, par value $0.0001 per share, to be
registered hereunder is contained in the section entitled “Description of
Securities” in the Prospectus included in the Registrant’s Registration
Statement on Form F-1/A (Registration No. 333-161602) filed with the Securities
and Exchange Commission on November 9, 2009, as amended from time to time (the
“Registration Statement”). This information is incorporated herein by reference.
Any form of prospectus or prospectus supplement to the Registration Statement
that includes such description and that are subsequently filed are hereby also
incorporated by reference herein.
Item
2. Exhibits.
Under the
Instructions as to Exhibits with respect to Form 8-A, no exhibits are required
to be filed because no other securities of the Registrant are registered on the
New York Stock Exchange and the securities registered hereby are not being
registered pursuant to Section 12(g) of the Securities Exchange Act of
1934, as amended.
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the
Registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereto duly authorized.
Date:
November 12, 2009
| CHINA CORD BLOOD CORPORATION | |||
|
|
By:
|
/s/ Ting Zheng | |
| Name: | Ting Zheng | ||
| Title: | Chief Executive Officer and Chairperson | ||